Sun Pharma

Sun Pharma is one of the...

• Forbes Global 2000 (#1362).

Sun Pharma is a company listed under the stock ticker SUNPHARMA (IN).

Sun Pharma has a direct presence in 2 countries.

Sun Pharma has 4 subsidiaries including Chattem Chemicals, Natco Pharma and Sun Pharma USA.

They are in:

• Pharmaceuticals80%
• Chemicals20%

Acquisition, funding and merger involving Sun Pharma.

• Sun Pharma has announced the acquisition of Concert Pharmaceuticals  (posted on January 24 2023).

View the org chart displaying its 68 main executives

Most searched biographies at Sun Pharma

• Dilip Shanghvi, Managing Director and Director
• Gautam Doshi, Director
• Sudhir Valia, Non-Independent Non-Executive Director

Popular executive movements at Sun Pharma

• Kalyanasundaram Subramanian, Executive Director, is retiring  (posted on February 1 2023).

Create your alert
to follow the executive moves at Sun Pharma.

Sun Pharma has 1,894 competitors including Pfizer (United States (USA)), Johnson & Johnson (United States (USA)) and Roche (Switzerland).

Popular M&A news in Pharmaceuticals

• Novo Holdings has announced the acquisition of Paratek Pharmaceuticals  (posted on June 7 2023).
• EQT has announced the acquisition of Dechra Pharmaceuticals  (posted on June 7 2023).
• Shin Nippon Biomedical Laboratories has announced the acquisition of Satsuma Pharmaceuticals  (posted on April 18 2023).

Popular contacts in Pharmaceuticals

• Danilo Cicmil - Supervisory Board Member at Galenika
• Jonathan Leff - Director at Larimar Therapeutics
• Alice Schardt-Rossmann - Managing Director at Dirk Rossmann

Learn more about the Pharmaceuticals industry >

Press releases by Sun Pharma

Social media about Sun Pharma

• Sun Pharma on Wikipedia, Google News & Yahoo Finance
• Sun Pharma on LinkedIn, Twitter & YouTube

Contact by email its executives including Rama Bijapurkar

Call Sun Pharma at +91 226...

View the org chart

Register to receive your alert

Report an error